» Articles » PMID: 39973939

Electroacupuncture Alleviates Functional Constipation by Upregulating Host-derived MiR-205-5p to Modulate Gut Microbiota and Tryptophan Metabolism

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2025 Feb 20
PMID 39973939
Authors
Affiliations
Soon will be listed here.
Abstract

Electroacupuncture (EA) has shown promise as a treatment for Functional constipation (FC), with growing evidence suggesting it may enhance gut motility. MicroRNAs (miRNAs) serve as key regulatory molecules mediating host-microbiota interactions. However, the specific fecal miRNAs regulating microbiota composition and metabolism in EA-treated constipated mice, along with their key targets, remain unidentified. We examined fecal microbiome composition, metabolism, and colonic miRNA expression in loperamide-induced constipated mice and EA-treated mice to identify differentially expressed miRNAs and assess their relationships with microbial abundance, metabolism, and gut motility. An antibiotic cocktail and adeno-associated virus were employed to interfere with the gut microbiota and target miRNA in vivo, thereby validating the proposed mechanism. Our results indicate that miR-205-5p, significantly upregulated in fecal and colonic tissues of EA-treated constipated mice, promotes intestinal motility in a microbiome-dependent manner. Specifically, EA promoted the growth of , enriched in the feces of constipation-recovered mice, through host-derived miR-205-5p regulation. Furthermore, and its tryptophan metabolites (indole-3-acetamide, indole-3-acetic acid, and indole-3-carboxaldehyde) alleviated loperamide-induced constipation. These findings underscore the pivotal role of host-derived miR-205-5p in modulating microbial composition and tryptophan metabolites to enhance intestinal motility through EA.

References
1.
Yao J, Yan X, Li Y, Chen Y, Xiao X, Zhou S . Altered gut microbial profile is associated with differentially expressed fecal microRNAs in patients with functional constipation. Front Microbiol. 2024; 14:1323877. PMC: 10808787. DOI: 10.3389/fmicb.2023.1323877. View

2.
Liu B, Wu J, Yan S, Zhou K, He L, Fang J . Electroacupuncture vs Prucalopride for Severe Chronic Constipation: A Multicenter, Randomized, Controlled, Noninferiority Trial. Am J Gastroenterol. 2020; 116(5):1024-1035. DOI: 10.14309/ajg.0000000000001050. View

3.
Palsson O, Whitehead W, Tornblom H, Sperber A, Simren M . Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020; 158(5):1262-1273.e3. DOI: 10.1053/j.gastro.2019.12.021. View

4.
Montgomery T, Eckstrom K, Lile K, Caldwell S, Heney E, Lahue K . Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. Microbiome. 2022; 10(1):198. PMC: 9685921. DOI: 10.1186/s40168-022-01408-7. View

5.
Vriesman M, Koppen I, Camilleri M, Di Lorenzo C, Benninga M . Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol. 2019; 17(1):21-39. DOI: 10.1038/s41575-019-0222-y. View